Ardent Health Partners, LLC (ARDT)
Automate Your Wheel Strategy on ARDT
With Tiblio's Option Bot, you can configure your own wheel strategy including ARDT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ARDT
- Rev/Share 44.9995
- Book/Share 11.6088
- PB 1.024
- Debt/Equity 1.8378
- CurrentRatio 2.0754
- ROIC 0.1612
- MktCap 1291552874.0
- FreeCF/Share 1.1019
- PFCF 8.3386
- PE 6.1833
- Debt/Assets 0.4415
- DivYield 0
- ROE 0.1709
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 3
- DCF Score 1
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | ARDT | KeyBanc Capital Markets | Overweight | Sector Weight | -- | -- | Nov. 17, 2025 |
| Downgrade | ARDT | Morgan Stanley | Overweight | Equal Weight | -- | -- | Nov. 14, 2025 |
| Initiation | ARDT | Goldman | -- | Neutral | -- | $19 | Oct. 14, 2025 |
| Initiation | ARDT | UBS | -- | Buy | -- | $17 | Sept. 10, 2025 |
| Downgrade | ARDT | BofA Securities | Neutral | Underperform | -- | $14.6 | July 16, 2025 |
| Resumed | ARDT | JP Morgan | -- | Neutral | -- | $20 | Dec. 17, 2024 |
| Initiation | ARDT | KeyBanc Capital Markets | -- | Overweight | -- | $24 | Oct. 11, 2024 |
News
ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit
Published: January 09, 2026 by: PRNewsWire
Sentiment: Neutral
NEW YORK, Jan. 9, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.
Read More
Ardent Health (ARDT) Hit With Securities Class Action Amid Receivables and Reserves Issues Driving 33% Plunge - Hagens Berman
Published: January 09, 2026 by: PRNewsWire
Sentiment: Neutral
SAN FRANCISCO, Jan. 9, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Ardent Health, Inc. (NYSE: ARDT) following the company's Q3 2025 financial disclosures that revealed significant adverse accounting adjustments totaling about $90 million and sent the stock tumbling over 33% in mid-November. The lawsuit seeks to represent investors who purchased or otherwise acquired Ardent securities between July 18, 2024 and November 12, 2025.
Read More
Securities Fraud Investigation Into Ardent Health, Inc. (ARDT) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Published: January 09, 2026 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ARDENT HEALTH, INC. (ARDT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On November 12, 2025, after market hours, Ardent released its third.
Read More
Rosen Law Firm Urges Ardent Health, Inc. (NYSE: ARDT) Stockholders to Contact the Firm for Information About Their Rights
Published: January 09, 2026 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025. Ardent Health describes itself as a company that “operates acute care hospitals and other healthcare facilities.” For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Al.
Read More
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Ardent Health, Inc. (ARDT) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
Published: January 09, 2026 by: GlobeNewsWire
Sentiment: Neutral
ATLANTA, Jan. 09, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Ardent Health, Inc. (“Ardent Health” or the “Company”) (NYSE: ARDT). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose that Ardent Health did not primarily rely on “detailed reviews of historical collections” in determining collectability of accounts receivable nor did “management determine[] [when an] account is uncollectible.” Instead, the Company's accounts receivable framework “utilized a 180-day cliff at which time an account became fully reserved.” This is alleged to have allowed Ardent Health to report higher amounts of accounts …
Read More
Could Ardent Health Be A Value Buy Right Now?
Published: January 09, 2026 by: Forbes
Sentiment: Positive
We believe Ardent Health (ARDT) stock deserves attention: It is growing, generating cash, and is priced significantly below its valuation. Companies like this can utilize cash to drive further revenue growth or distribute it to their shareholders via dividends or buybacks.
Read More
ARDENT HEALTH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ardent Health, Inc. and Encourages Investors to Contact the Firm
Published: January 08, 2026 by: GlobeNewsWire
Sentiment: Neutral
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Ardent Health (ARDT) To Contact Him Directly To Discuss Their Options
Read More
ARDT LAWSUIT ALERT: BFA Law Announces it has Filed a Class Action Lawsuit on behalf of Ardent Health, Inc. Investors after 33% Stock Drop -- Investors with Losses are Notified to Contact the Firm
Published: January 08, 2026 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE:ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-lawsuit.
Read More
Investor Notice: Robbins LLP Informs Investors of the Ardent Health, Inc. Securities Class Action
Published: January 08, 2026 by: Business Wire
Sentiment: Neutral
SAN DIEGO--(BUSINESS WIRE)---- $ARDT #ARDT--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2025 and November 12, 2025. Ardent Health and its affiliates operate acute care hospitals and other healthcare facilities. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegati.
Read More
ARDT BREAKING CLASS ACTION NEWS: BFA Law has Sued Ardent Health, Inc. for Securities Fraud after Collectability Issues lead to 33% Stock Drop -- Investors Notified to Contact the Firm
Published: January 08, 2026 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)---- $ARDT #ARDT--BFA Law has Sued Ardent Health, Inc. for Securities Fraud after Collectability Issues lead to 33% Stock Drop -- Investors Notified to Contact the Firm.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardent Health, Inc. - ARDT
Published: January 08, 2026 by: PRNewsWire
Sentiment: Neutral
NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ardent Health, Inc. ("Ardent" or the "Company") (NYSE: ARDT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardent Health, Inc. - ARDT
Published: January 06, 2026 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardent Health, Inc. - ARDT
Published: January 01, 2026 by: PRNewsWire
Sentiment: Neutral
NEW YORK, Jan. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ardent Health, Inc. ("Ardent" or the "Company") (NYSE: ARDT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardent Health, Inc. - ARDT
Published: December 30, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
Ardent Health (ARDT) Investor Alert: Hagens Berman Investigating Accounting Estimate Change and $97M Reserve Issue Driving 33% Plunge
Published: December 23, 2025 by: PRNewsWire
Sentiment: Neutral
Lead Partner Reed Kathrein: Scrutiny Focuses on Extent of Leadership Awareness Regarding Chronic Payor Denials and Collectability Issues SAN FRANCISCO , Dec. 23, 2025 /PRNewswire/ -- Prominent shareholder rights law firm Hagens Berman has opened an investigation into potential securities law violations by Ardent Health, Inc. (NYSE: ARDT) following the company's recent Q3 2025 financial disclosures. The disclosures revealed significant adverse accounting adjustments totaling $97 million that sent the stock tumbling over 33%.
Read More
ARDT INVESTIGATION: Robbins Geller Rudman & Dowd LLP Launches Investigation into Ardent Health, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
Published: December 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc. (NYSE: ARDT) focused on whether Ardent Health and certain of its executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information that could assist in the Ardent Health investigation or if you are an Ardent Health investor who suffered a loss and would like to learn more, you can provide your information here: https://www.rgrdlaw.com/cases-ardent-health-inc-investigation-ardt.html You can also contact attorneys J.C.
Read More
ARDT STOCK NOTICE: Ardent Health, Inc. Faces Securities Investigation after 33% Stock Drop – Investors with Losses Urged to Contact BFA Law
Published: December 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws. If you invested in Ardent, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-investigation.
Read More
Ardent Health, Inc. (NYSE: ARDT) Investigation Alert: Johnson Fistel Reviews Accounting Adjustment and Liability Reserve Increase Following Stock Drop
Published: December 15, 2025 by: PRNewsWire
Sentiment: Neutral
SAN DIEGO , Dec. 15, 2025 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Ardent Health, Inc. (NYSE: ARDT) or certain of its officers and directors violated federal securities laws by making false or misleading statements and/or failing to disclose material information to investors. Background of the Investigation On November 12, 2025, Ardent issued a press release announcing its financial results for the third quarter of 2025.
Read More
Ardent Health (ARDT) Investor Alert: Hagens Berman Investigating Accounting Estimate Change and $97M Reserve Issue Driving 33% Plunge
Published: December 11, 2025 by: PRNewsWire
Sentiment: Neutral
Lead Partner Reed Kathrein: Scrutiny Focuses on Extent of Leadership Awareness Regarding Chronic Payor Denials and Collectability Issues SAN FRANCISCO , Dec. 11, 2025 /PRNewswire/ -- Prominent shareholder rights law firm Hagens Berman has opened an investigation into potential securities law violations by Ardent Health, Inc. (NYSE: ARDT) following the company's recent Q3 2025 financial disclosures. The disclosures revealed significant adverse accounting adjustments totaling $97 million that sent the stock tumbling over 33%.
Read More
ARDT Investors Have Opportunity to Join Ardent Health, Inc. Fraud Investigation with the Schall Law Firm
Published: December 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Read More
Ardent Health (ARDT) Investor Alert: Hagens Berman Investigating Accounting Estimate Change and $97M Reserve Issue Driving 33% Plunge
Published: December 08, 2025 by: GlobeNewsWire
Sentiment: Neutral
Lead Partner Reed Kathrein: Scrutiny Focuses on Extent of Leadership Awareness Regarding Chronic Payor Denials and Collectability Issues Lead Partner Reed Kathrein: Scrutiny Focuses on Extent of Leadership Awareness Regarding Chronic Payor Denials and Collectability Issues
Read More
INVESTOR ALERT: Investigation of Ardent Health, Inc. (ARDT) by Holzer & Holzer, LLC
Published: December 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
ATLANTA, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) complied with federal securities laws. On November 12, 2025, Ardent announced third quarter 2025 results, revealing, among other things, that “[d]uring the third quarter, a change in accounting estimate resulting from a modification to the technique used to estimate the collectability of accounts receivable and new information provided by recently completed hindsight evaluations of historical collection trends resulted in a decrease in revenue of $43 million.” Following this news, the price of the Company's stock dropped.
Read More
ARDT Investors Have Opportunity to Join Ardent Health, Inc. Fraud Investigation with the Schall Law Firm
Published: December 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Read More
Ardent Health (ARDT) Investor Alert: Hagens Berman Investigating Accounting Estimate Change and $97M Reserve Issue Driving 33% Plunge
Published: November 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
Lead Partner Reed Kathrein: Scrutiny Focuses on Extent of Leadership Awareness Regarding Chronic Payor Denials and Collectability Issues Lead Partner Reed Kathrein: Scrutiny Focuses on Extent of Leadership Awareness Regarding Chronic Payor Denials and Collectability Issues
Read More
ARDT Investors Have Opportunity to Join Ardent Health, Inc. Fraud Investigation with the Schall Law Firm
Published: November 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Read More
Ardent Health (ARDT) Faces Investor Scrutiny Amid Problems Estimating Collection of Accounts Receivable, Disclosure Drives Stock Down 33% -- Hagens Berman
Published: November 26, 2025 by: PRNewsWire
Sentiment: Neutral
ARDT Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO , Nov. 26, 2025 /PRNewswire/ -- On November 13, 2025 investors in healthcare services provider Ardent Health (NYSE: ARDT) saw the price of their shares tumble $4.75 (-33%) after the company announced its Q3 2025 financial results, widely missing consensus EPS estimates and revealing two adverse items characterized as non-recurring. The developments and significant market reaction has prompted shareholder rights law firm Hagens Berman to open an investigation into whether Ardent Health may have violated the federal securities laws.
Read More
Ardent Health, Inc. Investigated by the Portnoy Law Firm
Published: November 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Ardent Health, Inc., (“Ardent" or the "Company") (NYSE: ARDT) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.
Read More
Ardent Health (ARDT) Faces Investor Scrutiny Amid Problems Estimating Collection of Accounts Receivable, Disclosure Drives Stock Down 33% -- Hagens Berman
Published: November 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- On November 13, 2025 investors in healthcare services provider Ardent Health (NYSE: ARDT) saw the price of their shares tumble $4.75 (-33%) after the company announced its Q3 2025 financial results, widely missing consensus EPS estimates and revealing two adverse items characterized as non-recurring.
Read More
Ardent Health, Inc. (NYSE: ARDT) Investigation Alert: Johnson Fistel Reviews Accounting Adjustment and Liability Reserve Increase Following Stock Drop
Published: November 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Ardent Health, Inc. (NYSE: ARDT) or certain of its officers and directors violated federal securities laws by making false or misleading statements and/or failing to disclose material information to investors.
Read More
ARDT INVESTORS: BFA Law Reminds Ardent Health, Inc. Investors with Losses to Contact the Firm About its Ongoing Securities Investigation
Published: November 20, 2025 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - November 20, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws. If you invested in Ardent, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-investigation.
Read More
About Ardent Health Partners, LLC (ARDT)
- IPO Date
- Website https://www.ardenthealth.com
- Industry Medical - Care Facilities
- CEO Martin J. Bonick
- Employees 19200